key: cord-0829097-8wh0n9j9 authors: Malieckal, Deepa A; Uppal, Nupur N; Ng, Jia H; Jhaveri, Kenar D; Hirsch, Jamie S title: Electrolyte abnormalities in patients hospitalized with COVID-19 date: 2021-03-16 journal: Clin Kidney J DOI: 10.1093/ckj/sfab060 sha: fb64acc130928e68460789b390a33db98f8c44fe doc_id: 829097 cord_uid: 8wh0n9j9 nan The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide pandemic and the disease it inflicts, Coronavirus Disease 2019 (COVID-19), has been found to impact multiple organ systems, including pulmonary, cardiovascular, neurologic, and kidney. In particular, while acute kidney injury (AKI) has been widely reported, other manifestations including electrolyte disturbances have been less well described. 1, 2 Early studies suggested that changes in serum sodium, potassium, chloride and calcium may be associated with infection and could be associated with disease severity. 3 At a large New York health system, we assessed data of over 10,000 patients hospitalized with COVID-19, to evaluate the prevalence at hospital presentation of the full spectrum of electrolyte disorders. Detailed methods of the study are located in the supplementary material. Between March 1, 2020, and April 27, 2020, 11635 patients were hospitalized for COVID-19, of which 10385 were included in our final cohort. While for most serum electrolytes, overall missingness was ≤0.1%, serum magnesium and serum phosphorus had a substantial missingness (28.5% and 39.8%, respectively). Overall, hyponatremia was the most commonly identified disorder (37.5%), followed by hypochloremia (26.0%) and hypocalcemia (18.3%) ( Table 1 ; see Figure 1B ). Among patients with eGFR <60 ml/min/1.73m 2 , 30.3% had hyponatremia, 11.1% had hyperkalemia, and 19.7% had hypochloremia ( Table 1 and Figure 1A ). Hypocalcemia was seen in 19.2% of patients. Hyperphosphatemia (13.9%) and hypermagnesemia (12.2%) were seen in a minority, however there was a significant amount of data missing (37.4% and 26.2% respectively) for this group. Kidney transplant patients also most commonly had hyponatremia (42.4%), hyperkalemia (16.7%), and hypochloremia (19%) ( Table 1 and Figure 1A) . In this group, hypophosphatemia (16.7%), hypomagnesemia (15.2%) and hypocalcemia (12.1%) were common, although many patients did not have these electrolytes checked (25.8%, 19.7%, and 1.5% respectively). Patients with ESKD were most commonly found to have hyponatremia (40.9%), hyperkalemia (23.4%) and hypochloremia (62%). Hyperphosphatemia (45.7%), hypermagnesemia (8.4%), and hypocalcemia (27.8%) were also seen (missingness of 26.8%, 23.2%, and 0.2%, respectively) ( Table 1 and Figure 1A) . This is the first and largest study to evaluate all electrolyte disorders noted in hospitalized patients with COVID-19. Hyponatremia was the most prevalent electrolyte abnormality, followed by hypochloremia and hypocalcemia. In Turkey, a study of 408 patients hospitalized with COVID-19, those with hyponatremia, hypochloremia and hypocalcemia had worse outcomes. 6 Patients with these types of abnormalities had underlying conditions like diabetes, hypertension, and coronary artery disease which may have contributed. In our population, it appears that overall low sodium, chloride, and calcium levels were evident regardless of kidney function, kidney transplant or dialysis status. We have previously demonstrated that ESKD and AKI in the setting of COVID-19 infection was associated with poor prognosis and death. 7,2 It is likely that electrolyte abnormalities further contributed to the severity of these conditions. Surprisingly, patients with lower eGFR had fewer electrolyte abnormalities, although missing data was common. Even in this cohort, hyponatremia was the most commonly encountered finding, which was seen in kidney transplant recipients as well. These latter patients also had a fair amount of magnesium and phosphate based disorders, likely a result of calcineurin inhibitor use. In ESKD patients, sodium related disorders and hyperkalemia along with hyperphosphatemia prevailed, which may simply be a result of dialysis status rather than specifically related to COVID-19. This study focused on prevalence at admission of electrolyte disorders seen with COVID-19 patients, without a focus on mortality and other outcomes. Thus, no causal relationship can be assigned to COVID-19 and any electrolyte disorder as either the disease, other comorbid conditions, or medications could account for the electrolyte changes. In summary, this study highlights the various electrolyte disorders in hospitalized COVID-19 patients. Overall, hyponatremia was the most commonly identified disorder, followed by hypochloremia and hypocalcemia. A majority of patients had at least one electrolyte abnormality on admission and several had multiple abnormalities. Further studies are needed to look at mortality outcomes related specifically to each electrolyte disorder. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int Clinical characteristics of 2019 novel coronavirus infection in China Hyperglycemia-induced hyponatremia--calculation of expected serum sodium depression Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and Better Risk Predictions Baseline electrolyte abnormalities would be related to poor prognosis in hospitalized coronavirus disease 2019 patients Acute kidney injury in patients hospitalized with COVID-19 The authors would like to thank the Raggio and Hall Families for their support and making this study possible.